Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis
暂无分享,去创建一个
Junyi Wang | Guoping Li | Ping He | Xiang He | Lei Zhang | Shengbin Liu | Yao Liu | Anying Xiong | M. Jiang | Liechao Luo | Q. Ran | Dehong Wu | Ying Xiong
[1] E. Petretto,et al. Cross-species integration of single-cell RNA-seq resolved alveolar-epithelial transitional states in idiopathic pulmonary fibrosis. , 2021, American journal of physiology. Lung cellular and molecular physiology.
[2] K. Jones,et al. The hidden history of hypersensitivity pneumonitis , 2021, European Respiratory Journal.
[3] J. Sznajder,et al. Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis , 2021, Proceedings of the National Academy of Sciences.
[4] Junyi Wang,et al. PM2.5 aggravates NQO1-induced mucus hyper-secretion through release of neutrophil extracellular traps in an asthma model. , 2021, Ecotoxicology and environmental safety.
[5] E. White,et al. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production , 2021, Journal of cellular physiology.
[6] Yan Liu,et al. Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients , 2020, Scientific Reports.
[7] Jonathan H. Chung,et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline , 2020, American journal of respiratory and critical care medicine.
[8] Fabian J. Theis,et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis , 2020, Nature Communications.
[9] Jianhong Ou,et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis , 2020, Nature Cell Biology.
[10] Ivana V. Yang,et al. Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures. , 2020, American journal of respiratory and critical care medicine.
[11] Zahra A. Premji,et al. Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis , 2020, European Respiratory Journal.
[12] Feng-Sheng Wang,et al. Epigenetic Regulation of Macrophage Marker Expression Profiles in Kawasaki Disease , 2020, Frontiers in Pediatrics.
[13] Yucheng Hu,et al. Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem Cells , 2019, Cell.
[14] Y. Saeys,et al. NicheNet: modeling intercellular communication by linking ligands to target genes , 2019, Nature Methods.
[15] Naftali Kaminski,et al. Single Cell RNA-seq reveals ectopic and aberrant lung resident cell populations in Idiopathic Pulmonary Fibrosis , 2019, bioRxiv.
[16] Jonathan A. Kropski,et al. Single-cell RNA-sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis , 2019, bioRxiv.
[17] P. Benos,et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis , 2019, European Respiratory Journal.
[18] A. Shilatifard,et al. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.
[19] Nir Hacohen,et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry , 2019, Nature Immunology.
[20] J. Ryu,et al. Exacerbation of Previously Undiagnosed Bird Fancier's Lung by Pembrolizumab Therapy. , 2019, Chest.
[21] L. Delgado,et al. NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis , 2019, BMC Pulmonary Medicine.
[22] Atul J. Butte,et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.
[23] W. Gu,et al. Macrophages: friend or foe in idiopathic pulmonary fibrosis? , 2018, Respiratory Research.
[24] F. Martinez,et al. Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement. , 2018, American journal of respiratory and critical care medicine.
[25] Y. Kluger,et al. KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity , 2018, Immunity.
[26] Peter Chen,et al. Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis , 2018, Cell reports.
[27] F. Martinez,et al. Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go , 2017, American journal of respiratory and critical care medicine.
[28] Q. Ye,et al. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis , 2017, Respiratory Research.
[29] N. Girard,et al. Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients , 2017, European Respiratory Journal.
[30] J. Aerts,et al. SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.
[31] Andrew J. Hill,et al. Single-cell mRNA quantification and differential analysis with Census , 2017, Nature Methods.
[32] J. Taube,et al. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.
[33] P. Linsley,et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.
[34] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[35] H. Moch,et al. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma , 2013, Oncoimmunology.
[36] D. Caillaud,et al. Bronchoalveolar lavage in hypersensitivity pneumonitis: a series of 139 patients. , 2012, Inflammation & allergy drug targets.
[37] M. Gaxiola,et al. The effect of CTLA-4Ig, a CD28/B7 antagonist, on the lung inflammation and T cell subset profile during murine hypersensitivity pneumonitis. , 2011, Experimental and molecular pathology.
[38] W. Born,et al. Th17-Polarized Immune Response in a Murine Model of Hypersensitivity Pneumonitis and Lung Fibrosis1 , 2009, The Journal of Immunology.
[39] T. Akashi,et al. Pathology of hypersensitivity pneumonitis , 2008, Current opinion in pulmonary medicine.
[40] T. Isobe,et al. [Hypersensitivity pneumonitis]. , 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.